← Alle mensen

KW

Kana Watanabe

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Gefitinib alleen versus gefitinib plus chemotherapie bij NSCLC: NEJ009 update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 november 2022

Osimertinib versus osimertinib plus chemotherapie bij T790M NSCLC

European journal of cancer (Oxford, England : 1990) · 2021-05

Erlotinib plus bevacizumab versus erlotinib bij EGFR-positief NSCLC: NEJ026 fase III

The Lancet. Oncology · 2019-05